Kenvue Inc
KVUE21.590USD
+0.150+0.70%
Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min
41.43BCap. mercado
39.23P/E TTM
Más Datos de Kenvue Inc Compañía
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Información de la empresa
Símbolo de cotizaciónKVUE
Nombre de la empresaKenvue Inc
Fecha de salida a bolsaMay 04, 2023
Fundada en2022
Director ejecutivoMr. Kirk L. Perry
Número de empleados22000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 04
Dirección1 Kenvue Way
CiudadSUMMIT
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal07901
Teléfono19088741200
Sitio Webhttps://www.kenvue.com
Símbolo de cotizaciónKVUE
Fecha de salida a bolsaMay 04, 2023
Fundada en2022
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
27.46K
+124.86%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
25.25K
+15.69%
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
17.80K
+122.51%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Face and Body Care
673.38M
18.00%
Cough, Cold and Allergy
598.56M
16.00%
Other Self Care
598.56M
16.00%
Pain Care
486.33M
13.00%
Other Essential Health
374.10M
10.00%
Other
1.01B
27.00%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Face and Body Care
673.38M
18.00%
Cough, Cold and Allergy
598.56M
16.00%
Other Self Care
598.56M
16.00%
Pain Care
486.33M
13.00%
Other Essential Health
374.10M
10.00%
Other
1.01B
27.00%
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.15%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
60.97%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.15%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
60.97%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
56.49%
Investment Advisor/Hedge Fund
32.81%
Hedge Fund
4.38%
Research Firm
3.21%
Pension Fund
1.76%
Sovereign Wealth Fund
1.38%
Bank and Trust
1.18%
Family Office
0.19%
Family Office
0.19%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
2088
1.95B
101.44%
-295.31M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
2023Q1
1
--
0.00%
-14.23K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
228.31M
11.89%
+10.60M
+4.87%
Mar 31, 2025
T. Rowe Price Associates, Inc.
208.36M
10.85%
-33.69M
-13.92%
Mar 31, 2025
State Street Global Advisors (US)
120.27M
6.26%
-134.23K
-0.11%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
94.32M
4.91%
+1.26M
+1.36%
Mar 31, 2025
MFS Investment Management
93.09M
4.85%
-771.33K
-0.82%
Mar 31, 2025
Fidelity Management & Research Company LLC
92.37M
4.81%
-13.82M
-13.02%
Mar 31, 2025
Wellington Management Company, LLP
61.47M
3.2%
-6.89M
-10.08%
Mar 31, 2025
Geode Capital Management, L.L.C.
48.40M
2.52%
+2.33M
+5.05%
Mar 31, 2025
Harris Associates L.P.
26.88M
1.4%
-4.64M
-14.71%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
25.61M
1.33%
+633.46K
+2.54%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: hace 3 horas
Actualizado: hace 3 horas
Nombre
Proporción
Renaissance IPO ETF
9.18%
TBG Dividend Focus ETF
3.64%
American Century Focused Large Cap Value ETF
3.63%
Brookstone Value Stock ETF
3.54%
Cullen Enhanced Equity Income ETF
3.4%
TrueShares Low Volatility Equity Income ETF
3.16%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.53%
VanEck Morningstar Wide Moat Value ETF
2.53%
ProShares Ultra Consumer Staples
2.52%
Consumer Staples Select Sector SPDR Fund
2.52%
Ver más
Renaissance IPO ETF
Proporción9.18%
TBG Dividend Focus ETF
Proporción3.64%
American Century Focused Large Cap Value ETF
Proporción3.63%
Brookstone Value Stock ETF
Proporción3.54%
Cullen Enhanced Equity Income ETF
Proporción3.4%
TrueShares Low Volatility Equity Income ETF
Proporción3.16%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proporción2.53%
VanEck Morningstar Wide Moat Value ETF
Proporción2.53%
ProShares Ultra Consumer Staples
Proporción2.52%
Consumer Staples Select Sector SPDR Fund
Proporción2.52%
Dividendos
Un total de
2.32B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
